Evidence map›Paper›PMID 36515362›Full record

Trial reportPalliative medicine2023

Healthcare use and healthcare costs for patients with advanced cancer; the international ACTION cluster-randomised trial on advance care planning.

Ida J Korfage, Suzanne Polinder, Nancy Preston, Johannes Jm van Delden, Sandra A Jlm Geraerds, Lesley Dunleavy, Kristof Faes, Guido Miccinesi, Giulia Carreras, Caroline Moeller Arnfeldt and 9 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Palliative medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ida J KorfageDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-6538-9115
Suzanne PolinderDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Nancy PrestonInternational Observatory on End of Life Care, Division of Health Research, Lancaster University, Lancaster, UK.ORCID 0000-0003-2659-2342
Johannes Jm van DeldenJulius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.
Sandra A Jlm GeraerdsDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-1332-0500
Lesley DunleavyInternational Observatory on End of Life Care, Division of Health Research, Lancaster University, Lancaster, UK.ORCID 0000-0002-5924-8145
Kristof FaesEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
Guido MiccinesiClinical Epidemiology, Oncological network, prevention and research Institute (ISPRO), Florence, Italy.
Giulia CarrerasClinical Epidemiology, Oncological network, prevention and research Institute (ISPRO), Florence, Italy.
Caroline Moeller ArnfeldtDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Marijke C KarsJulius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-5680-4559
Giuseppe LippiTuscany Region Health Agency, Italy.
Urska LunderUniversity Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
Ceu MateusDivision of Health Research, Lancaster University, Lancaster, UK.ORCID 0000-0001-6219-219X
Kristian PollockSchool of Health Sciences, University of Nottingham, Nottingham, UK.
Luc DeliensEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.ORCID 0000-0002-8158-2422
Mogens GroenvoldDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Agnes van der HeideDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Judith Ac RietjensDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0002-0538-5603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvance care planning supports patients to reflect on and discuss preferences for future treatment and care. Studies of the impact of advance care planning on healthcare use and healthcare costs are scarce.

aimTo determine the impact on healthcare use and costs of an advance care planning intervention across six European countries.

designCluster-randomised trial, registered as ISRCTN63110516, of advance care planning conversations supported by certified facilitators. SETTING/

participantsPatients with advanced lung or colorectal cancer from 23 hospitals in Belgium, Denmark, Italy, the Netherlands, Slovenia and the UK. Data on healthcare use were collected from hospital medical files during 12 months after inclusion.

resultsPatients with a good performance status were underrepresented in the intervention group (

conclusionsLower care costs as observed in the intervention group were mainly related to patients' characteristics. A definite impact of the intervention itself could not be established.

Indexed as

Advance Care PlanningNeoplasmsDelivery of Health CareEuropeHealth Care CostsHumansAdvance care planningcancerdelivery of health carehealth care costsrandomised controlled trial

Identifiers

PMID36515362
PMCPMC10227094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.